The prognostic role of D-Dimer, C-reactive protein (CRP), and fibrinogen levels in the incidence of thromboembolic events and mortality in COVID-19 patients is well-known and has been extensively researched in the specialized literature over the last two years [25,26,27,28,29,30,31]. The gene discussed is CRP; the disease is COVID-19.